MetLife Investment Management, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$941,277
-20.0%
20,4670.0%0.01%
-22.2%
Q2 2023$1,176,238
+53.3%
20,4670.0%0.01%
+50.0%
Q1 2023$767,513
+33.8%
20,4670.0%0.01%
+20.0%
Q4 2022$573,485
-0.3%
20,4670.0%0.01%0.0%
Q3 2022$575,123
-19.2%
20,4670.0%0.01%
-16.7%
Q2 2022$712,047
-3.1%
20,4670.0%0.01%
+20.0%
Q1 2022$734,765
+167.3%
20,467
+73.4%
0.01%
+150.0%
Q4 2021$274,892
+22.5%
11,8030.0%0.00%0.0%
Q3 2021$224,375
-5.7%
11,8030.0%0.00%0.0%
Q2 2021$237,948
+10.0%
11,8030.0%0.00%0.0%
Q1 2021$216,231
-40.9%
11,803
-35.2%
0.00%
-50.0%
Q4 2020$366,103
+7.3%
18,2050.0%0.00%0.0%
Q3 2020$341,344
-16.5%
18,2050.0%0.00%
-20.0%
Q2 2020$408,884
+51.3%
18,2050.0%0.01%
+25.0%
Q1 2020$270,162
-23.1%
18,2050.0%0.00%0.0%
Q4 2019$351,174
-2.7%
18,2050.0%0.00%0.0%
Q3 2019$361,005
-6.1%
18,2050.0%0.00%0.0%
Q2 2019$384,308
+3.3%
18,2050.0%0.00%0.0%
Q1 2019$371,928
+2.7%
18,2050.0%0.00%
-20.0%
Q4 2018$362,280
+3.4%
18,2050.0%0.01%
+25.0%
Q3 2018$350,264
+26.0%
18,2050.0%0.00%
+33.3%
Q2 2018$278,000
-18.5%
18,2050.0%0.00%
-25.0%
Q1 2018$341,000
-2.6%
18,2050.0%0.00%0.0%
Q4 2017$350,00018,2050.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders